Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Interest & Investment Income (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Interest & Investment Income for 17 consecutive years, with $800000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 166.67% to $800000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 5.88% increase, with the full-year FY2025 number at $1.8 million, up 5.88% from a year prior.
  • Interest & Investment Income was $800000.0 for Q4 2025 at Myriad Genetics, up from $500000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q3 2022 to a low of $100000.0 in Q4 2021.
  • A 5-year average of $465000.0 and a median of $400000.0 in 2022 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: plummeted 85.71% in 2021, then skyrocketed 900.0% in 2022.
  • Myriad Genetics' Interest & Investment Income stood at $100000.0 in 2021, then surged by 900.0% to $1.0 million in 2022, then fell by 30.0% to $700000.0 in 2023, then tumbled by 57.14% to $300000.0 in 2024, then surged by 166.67% to $800000.0 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Interest & Investment Income are $800000.0 (Q4 2025), $500000.0 (Q3 2025), and $200000.0 (Q2 2025).